Technical Analysis for PTCT - PTC Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 17.79 0.68% 0.12
PTCT closed up 0.68 percent on Friday, October 20, 2017, on 60 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: Nov 1

Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical PTCT trend table...

Date Alert Name Type % Chg
Oct 20 NR7 Range Contraction 0.00%
Oct 20 Narrow Range Bar Range Contraction 0.00%
Oct 20 Stochastic Reached Oversold Other 0.00%
Oct 18 Doji - Bearish? Reversal -2.52%
Oct 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.52%

Older signals for PTCT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and proprietary small-molecule drugs for patients living with serious and life-threatening conditions, including genetic and neuromuscular disorders, cancer, and infectious diseases. Its approach includes post-transcriptional control, RNA biology, and gene expression modulation by small-molecules. The company has strategic alliances with AstraZeneca; Celgene Corporation; Cystic Fibrosis Foundation; Genzyme Corporation; Gilead; Muscular Dystrophy Association; Merck & Co., Inc.; Parent Project Muscular Dystrophy; Pfizer Inc.; Roche; Spinal Muscular Atrophy Foundation; and Wellcome Trust. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.
Is PTCT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 22.0
52 Week Low 4.03
Average Volume 1,134,886
200-Day Moving Average 15.3636
50-Day Moving Average 19.1342
20-Day Moving Average 18.4515
10-Day Moving Average 17.984
Average True Range 1.0773
ADX 17.93
+DI 16.71
-DI 23.94
Chandelier Exit (Long, 3 ATRs ) 18.3481
Chandelier Exit (Short, 3 ATRs ) 17.7919
Upper Bollinger Band 20.4787
Lower Bollinger Band 16.4243
Percent B (%b) 0.34
BandWidth 21.973281
MACD Line -0.4341
MACD Signal Line -0.3687
MACD Histogram -0.0654
Fundamentals Value
Market Cap 734.8 Million
Num Shares 41.3 Million
EPS -3.05
Price-to-Earnings (P/E) Ratio -5.83
Price-to-Sales 6.70
Price-to-Book 4.84
PEG Ratio 0.89
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.39
Resistance 3 (R3) 18.39 18.19 18.29
Resistance 2 (R2) 18.19 18.04 18.19 18.26
Resistance 1 (R1) 17.99 17.94 18.09 17.99 18.22
Pivot Point 17.79 17.79 17.84 17.79 17.79
Support 1 (S1) 17.59 17.64 17.69 17.59 17.36
Support 2 (S2) 17.39 17.54 17.39 17.32
Support 3 (S3) 17.19 17.39 17.29
Support 4 (S4) 17.19